Okyo Pharma Limited
-
USPTO grants patent for Okyo’s dry eye drug candidate OK-101 for use to treat ocular neuropathic pain
140 0Okyo Pharma Limited, a biotechnology company focused on the discovery…
Read more
Okyo Pharma Limited, a biotechnology company focused on the discovery…
Read more